Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

被引:168
作者
Engwegen, Judith Y. M. N.
Helgason, Helgi H.
Cats, Annemieke
Harris, Nathan
Bonfrer, Johannes M. G.
Schellens, Jan H. M.
Beijnen, Jos H.
机构
[1] Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, NL-1006 BK Amsterdam, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[3] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Ciphergen Biosyst Inc, Fremont, CA USA
[5] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Clin Chem, Amsterdam, Netherlands
[6] Univ Utrecht, Fac Pharmaceut Sci, Dept Biomed Anal, Utrecht, Netherlands
关键词
proteomics; colorectal cancer; biomarker; sensitivity; specificity;
D O I
10.3748/wjg.v12.i10.1536
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surface-enhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set A: 40 CRC + 49 healthy controls; set B: 37 CRC + 31 healthy controls), using chips with a weak cation exchange moiety and buffer pH 5. Discriminative power of differentially expressed proteins was assessed with a classification tree algorithm. Sensitivities and specificities of the generated classification trees were obtained by blindly applying data from set A to the generated trees from set B and vice versa. CRC serum protein profiles were also compared with those from breast, ovarian, prostate, and non-small cell lung cancer. RESULTS: Mass-to-charge ratios (m/z) 3.1x10(3), 3.3x 10(3), 4.5x10(3), 6.6x10(3) and 28x10(3) were used as classifiers in the best-performing classification trees. Tree sensitivities and specificities were between 65% and 90%. Most of these discriminative m/z values were also different in the other tumour types investigated. M/z 3.3x 10(3), main classifier in most trees, was a doubly charged form of the 6.6x10(3)-Da protein. The latter was identified as apolipoprotein C-I. M/z 3.1x10(3) was identified as an N-terminal fragment of albumin, and m/z 28x10(3) as apolipoprotein A-I. CONCLUSION: SELDI-TOF MS followed by classification tree pattern analysis is a suitable technique for finding new serum markers for CRC. Biomarkers can be identified and reproducibly detected in independent sample sets with high sensitivities and specificities. Although not specific for CRC, these biomarkers have a potential role in disease and treatment monitoring. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:1536 / 1544
页数:9
相关论文
共 33 条
[1]
Adam BL, 2002, CANCER RES, V62, P3609
[2]
ACCURACY OF FECAL OCCULT BLOOD SCREENING FOR COLORECTAL NEOPLASIA - A PROSPECTIVE-STUDY USING HEMOCCULT AND HEMOQUANT TESTS [J].
AHLQUIST, DA ;
WIEAND, HS ;
MOERTEL, CG ;
MCGILL, DB ;
LOPRINZI, CL ;
OCONNELL, MJ ;
MAILLIARD, JA ;
GERSTNER, JB ;
PANDYA, K ;
ELLEFSON, RD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (10) :1262-1267
[3]
ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke [J].
Allard, L ;
Lescuyer, P ;
Burgess, J ;
Leung, KY ;
Ward, M ;
Walter, N ;
Burkhard, PR ;
Corthals, G ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2004, 4 (08) :2242-2251
[4]
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology [J].
Bast, RC ;
Ravdin, P ;
Hayes, DF ;
Bates, S ;
Fritsche, H ;
Jessup, JM ;
Kemeny, N ;
Locker, GY ;
Mennel, RG ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1865-1878
[5]
Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins [J].
Chen, W ;
Ji, JG ;
Xu, XM ;
He, SZ ;
Ru, BG .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2003, 21 (04) :209-216
[6]
Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population [J].
Chen, YD ;
Zheng, S ;
Yu, JK ;
Hu, X .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8380-8385
[7]
ProteinChip technology: A new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease [J].
Dayal, B ;
Ertel, NH .
JOURNAL OF PROTEOME RESEARCH, 2002, 1 (04) :375-380
[8]
Duffy MJ, 2001, CLIN CHEM, V47, P624
[9]
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines [J].
Duffy, MJ ;
van Dalen, A ;
Haglund, C ;
Hansson, L ;
Klapdor, R ;
Lamerz, R ;
Nilsson, O ;
Sturgeon, C ;
Topolcan, O .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) :718-727
[10]
Proteolysis in colorectal cancer [J].
Garbett, EA ;
Reed, MWR ;
Brown, NJ .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (03) :140-145